Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV
Stopped early · Phase 2
Conditions studied: HIV Infections
In brief
Although some doctors favor starting anti-HIV treatment as soon as possible after patients learn they are infected, it is not known if treatment for recently infected patients results in long-term benefits or harm. The purpose of this study is to learn whether or not people should take anti-HIV drugs when they are first infected.
Key facts
- Study ID
- NCT00090779
- Run by
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- People needed
- 130
- Starts
- 2005-01-01
- Expected to finish
- 2011-05-01
- Last updated by the study team
- 2018-10-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Ucsd, Avrc Crs (701) — San Diego, California, United States
- Ucsf Aids Crs (801) — San Francisco, California, United States
- Harbor-UCLA Med. Ctr. CRS (603) — Torrance, California, United States
- University of Colorado Hospital CRS (6101) — Aurora, Colorado, United States
- University of Miami AIDS CRS (901) — Miami, Florida, United States
- The Ponce de Leon Center CRS — Atlanta, Georgia, United States
- Northwestern University CRS (2701) — Chicago, Illinois, United States
- Rush Univ. Med. Ctr. ACTG CRS (2702) — Chicago, Illinois, United States
- Indiana University Hospital (2601) — Indianapolis, Indiana, United States
- IHV Baltimore Treatment CRS (4651) — Baltimore, Maryland, United States
- Massachusetts General Hospital ACTG CRS (101) — Boston, Massachusetts, United States
- Brigham and Women's Hosp. ACTG CRS (107) — Boston, Massachusetts, United States
- Washington University CRS (2101) — St Louis, Missouri, United States
- Beth Israel Medical Center — New York, New York, United States
- HIV Prevention & Treatment CRS (30329) — New York, New York, United States
- AIDS Care CRS (1108) — Rochester, New York, United States
- University of Rochester ACTG CRS (1101) — Rochester, New York, United States
- Unc Aids Crs (3201) — Chapel Hill, North Carolina, United States
- Moses H. Cone Memorial Hospital CRS (3203) — Greensboro, North Carolina, United States
- Regional Center for Infectious Disease, Wendover Medical Center CRS (3203) — Greensboro, North Carolina, United States
- The Ohio State Univ. AIDS CRS (2301) — Columbus, Ohio, United States
- Hosp. of the Univ. of Pennsylvania CRS (6201) — Philadelphia, Pennsylvania, United States
- The Miriam Hosp. ACTG CRS (2951) — Providence, Rhode Island, United States
- University of Washington AIDS CRS (1401) — Seattle, Washington, United States
- UW Primary Infection Clinic CRS (1404) — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.